IQVIA (IQV) Fair Value & DCF
Score
IQV fair value $326.45. Price $263.79. Price is 19% below fair value.
Worked example
Cash-flow value. Starting free cash flow is $12.62 a share. Year 1 is the first earnings forecast, so it has no growth rate of its own. The forecast then reaches 9.66%, and that pace fades in a straight line to 3% terminal growth by year 10. The discount rate is 10.70% (beta 1.16). It is beta-adjusted and capped at 12%. The cash-flow value is $239.52 a share.
Earnings value. Next-twelve-months earnings per share of $13.78 times 30.00 is $413.38. The peer group is Medical - Diagnostics & Research, 12 companies worth at least $10 billion. Peer median 33.2. Own 10-year median 45.5. The multiple used is the average of the two, kept between 8 and 30, which is 30.00.
Fair value is the average of the two, $326.45. The price is $263.79, which is 19.2% below fair value.